FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:595-603 August 11, 2005 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 63-year-old woman presents with a history of acute low back pain. She had menopause at 44 years of age but never received postmenopausal hormone-replacement therapy. She reports a history of a Colles' fracture at the age of 60 years. Her mother sustained a hip fracture at 70 years of age. Lumbar-spine films reveal a new vertebral fracture. Dual-energy x-ray absorptiometry of . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Overview

Planning an Intervention Strategy

Nonpharmacologic Options

            Physical Activity

Pharmacologic Options

            Antiresorptive Agents

            Postmenopausal Hormone-Replacement Therapy

            Selective Estrogen-Receptor Modulators

            Bisphosphonates

            Calcitonin

            Strontium Ranelate

            Anabolic Agents

            Combination Therapy

Areas of Uncertainty

Guidelines

Summary and Recommendations

Source Information

From St. Joseph Hospital, Maine Center for Osteoporosis Research and Education, Bangor.

Address reprint requests to Dr. Rosen at St. Joseph Hospital, 900 Broadway, Bldg. 2, Bangor, ME 04401, or at rofe@aol.com.

Related Letters:

Postmenopausal Osteoporosis
Chan A. S., Rosen C. J.
Extract | Full Text | PDF  
N Engl J Med 2005; 353:1974-1975, Nov 3, 2005. Correspondence

This article has been cited by other articles:

• El-Hajj Fuleihan, G. (2008). Tibolone and the Promise of Ideal Hormone-Replacement Therapy. NEJM 359: 753-755 [Full Text]  
• Woodis, C B. (2008). Once-Yearly Administered Intravenous Zoledronic Acid for Postmenopausal Osteoporosis. The Annals of Pharmacotherapy 42: 1085-1089 [Abstract] [Full Text]  
• Rozental, T. D., Makhni, E. C., Day, C. S., Bouxsein, M. L. (2008). Improving Evaluation and Treatment for Osteoporosis Following Distal Radial Fractures. A Prospective Randomized Intervention. JBJS 90: 953-961 [Abstract] [Full Text]  
• Cauley, J. A., Ensrud, K. E. (2008). Considering Competing Risks . . . Not All Black and White. Arch Intern Med 168: 793-795 [Full Text]  
• Raje, N., Woo, S.-B., Hande, K., Yap, J. T., Richardson, P. G., Vallet, S., Treister, N., Hideshima, T., Sheehy, N., Chhetri, S., Connell, B., Xie, W., Tai, Y.-T., Szot-Barnes, A., Tian, M., Schlossman, R. L., Weller, E., Munshi, N. C., Van Den Abbeele, A. D., Anderson, K. C. (2008). Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the Jaw. Clin. Cancer Res. 14: 2387-2395 [Abstract] [Full Text]  
• Jadoul, M. (2007). Towards the prevention of bone fractures in dialysed patients?. Nephrol Dial Transplant 22: 3377-3380 [Full Text]  
• Tauchmanova, L., Colao, A., Lombardi, G., Rotoli, B., Selleri, C. (2007). REVIEW: Bone Loss and Its Management in Long-Term Survivors from Allogeneic Stem Cell Transplantation. J. Clin. Endocrinol. Metab. 92: 4536-4545 [Abstract] [Full Text]  
• Mayes, S. L. (2007). Review of Postmenopausal Osteoporosis Pharmacotherapy. Nutr Clin Pract 22: 276-285 [Abstract] [Full Text]  
• Khosla, S., Melton, L. J. III (2007). Osteopenia. NEJM 356: 2293-2300 [Full Text]  
• Greenspan, S. L., Nelson, J. B., Trump, D. L., Resnick, N. M. (2007). Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial. ANN INTERN MED 146: 416-424 [Abstract] [Full Text]  
• Armamento-Villareal, R., Napoli, N., Panwar, V., Novack, D. (2006). Suppressed Bone Turnover during Alendronate Therapy for High-Turnover Osteoporosis. NEJM 355: 2048-2050 [Full Text]  
• Schwartzman, J., Yazici, Y., Rifkin, W. D., McClung, M. R. (2006). Denosumab in postmenopausal women with low bone mineral density.. NEJM 354: 2390-2391 [Full Text]  
• Perrien, D. S., Achenbach, S. J., Bledsoe, S. E., Walser, B., Suva, L. J., Khosla, S., Gaddy, D. (2006). Bone Turnover across the Menopause Transition: Correlations with Inhibins and Follicle-Stimulating Hormone. J. Clin. Endocrinol. Metab. 91: 1848-1854 [Abstract] [Full Text]  
• Chan, A. S., Rosen, C. J. (2005). Postmenopausal osteoporosis.. NEJM 353: 1974-1975 [Full Text]